chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Our clerical person was going through Immtrac forms and making sure information was in the national system.  She brought it to my attention that this gentleman has received four (4) Moderna vaccines at several different facilities.  We gave him #2 only. I have reached out to him however he is not answering or returning my calls.
Vaccine administered on 5/24/21, patient reports feeling very fatigued from 6/8 to 6/11 as well as moderate diarrhea on 6/11 and 6/12.
18 hours after injection, began feeling joint and muscle aches. At about 19 hours post-injection, the aches became nearly unbearable and remained this way until about 36 hours post-injection. Also around 19 hours post-injection, became severely nauseous and vomited, almost fainted. Vomited a second time over the course of the symptoms, frequent bouts of mild to severe nausea. Severe headache. Severe fatigue throughout symptoms. Joint/muscle aches moved from all over to focus on hips, then neck and shoulders where patient has chronic pain, then middle back. Fever began at about 19 hours at 100.6; highest recorded at 101.7 around 24-28 hours, declined to 99.1 by 36 hours, no fever by about 40 hours. Full recovery from bouts of nausea, headache, lack of appetite, mild to severe fatigue, general malaise did not occur until approximately six (6) days after injection.
Sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 939902) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Sore arm). At the time of the report, PAIN IN EXTREMITY (Sore arm) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.       No concomitant and treatment drugs were reported.  No treatment information was reported.  Reporter stated that his wife got the booster dose too early, because of the negligence of the pharmacist. It was 24 days before the 5 months details included Booster dose on 08Jan2022 ,Lot - 033H21A.    This case was linked to MOD-2022-467313, MOD-2022-467315 (Patient Link).
March 25 woke up with screaming headache, nausea. Could only lie on back. Slept until 7:00 a.m. March 26. Headache was greatly diminished. But left arm at injection site was itching and red. Called  Health and left message for nurse. Nurse left voicemail late in afternoon saying I needed to talk to COVID specialist. Left message for COVID specialist. Did not hear back. By March 27 injection site was a 3"x2" red raised welt, very uncomfortable. I did speak with weekend nurse, who advised going to Urgent Care because it was the weekend. Since I would have to drive 40 minutes I opted for natural antihistamine methods - quercetin, nettle, a couple of other things. Welt began to diminish by 1/2". By Monday. It was just red, not raised. I believe it was an allergic reaction to some ingredient in the vaccine.
Patient received Anthrax #5 and influenza on 3 June 2003.  The evening following vaccination, aproximately 6-8 hours, he developed multiple papule/urticaria lesions on the lower extremities that progressed to the lower back,abdomen,arms and shoulders. The rash non-erythematous and pruritic lasting 15 minutes.  The rash reoccurred one week later around the same time in the evening.  He was treated with benadryl and zyrtec.  Symptoms resolved.  Two weeks later, he was deployed.  During his deployment, he experienced 3 more episodes of urticaria.  The third episode consisted of facial swelling of the lips, eye lids and testicular area lasting several hours.   Since his return from deployment in August, he has not had any further outbreaks.
migraine; arm pain; Muscle pain; right arm of injection hurt; This spontaneous case was reported by a consumer and describes the occurrence of MIGRAINE (migraine), PAIN IN EXTREMITY (arm pain), MYALGIA (Muscle pain) and INJECTION SITE PAIN (right arm of injection hurt) in a 23-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 02SO20A and 013M20A) for COVID-19 vaccination.     Concurrent medical conditions included Asthma and Allergy. Concomitant products included PROLIFE for Asthma, ZINC and VITAMIN B COMPLEX for an unknown indication.   On 11-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced MIGRAINE (migraine), PAIN IN EXTREMITY (arm pain), MYALGIA (Muscle pain) and INJECTION SITE PAIN (right arm of injection hurt). The patient was treated with IBUPROFEN at an unspecified dose and frequency. At the time of the report, MIGRAINE (migraine), PAIN IN EXTREMITY (arm pain), MYALGIA (Muscle pain) and INJECTION SITE PAIN (right arm of injection hurt) outcome was unknown.            The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) was not applicable.   This case was linked to MOD-2021-030576 (Patient Link).
Received injection at 3:30 pm began having breathing difficulties at 8 pm. Started with cough and restricted breathing. Went to hospital for treatment.
warm rush of liquid through arm, dizziness, felt faint and disoriented and then extremely tired - symptoms lasted until approx. 4 pm
patient reported pain that was traveling down the arm. she did not notice any redness or heat in the area.  There was no discoloration but the pain was there and she came in in march and reported the pain that was traveling down the arm .
Shingles (QCR positive for zoster ); This case was reported by a physician via call center representative and described the occurrence of shingles in a 54-year-old male patient who received Herpes zoster (Shingrix) (batch number OID21A, expiry date unknown) for prophylaxis.   On 5th December 2022, the patient received the 1st dose of Shingrix. In December 2022, 1 week after receiving Shingrix, the patient experienced shingles. On an unknown date, the outcome of the shingles was unknown.   It was unknown if the reporter considered the shingles to be related to Shingrix.     Additional Information: GSK Receipt Date: 19-DEC-2022 Reporter's Comments: The reporter reported that the patient developed shingles a week later after receiving first dose of Shingrix. QCR positive for zoster. The vaccine administration facility was the same as primary reporter The reporter was consented to follow up. Note: QCR test coded as PCR as per confirmation.
At first - immediate - woozy feeling; dizzy. And then I felt spacey and my face felt congested - kind of like I was getting an allergic reaction - like I was getting stuffed up. I still had the headache I had been experiencing  since the first vaccine- I felt  really run down. The next day, freezing, body aches; fever -101 and that was lasting until midnight that night and I woke feeling like chills went away but I felt run down that day. The next day, I woke up feeling great. Two days later, I was rubbing my neck and I felt a lump under my collarbone and I messaged my doctor the next day. It was on the left side. It did go away by the end of one week. (Note: I did not have a lump under my collarbone for the first dose of the vaccine.)  Did do chiropractor visits March 4 and March 26th.  for the headache that was an adverse event after first vaccine.
Upon withdrawing, the syringe and the needle were detached. The Needle was removed. Patient notified that he received all the medication.
Had swollen and painful joints that will not get better; fibromyalgia; anxiety and fatigue. Treated with heat and cold compresses and ultrasound and anti-inflammatories.  Follow up:  Follow up in 2 weeks, may need to have Rheumatologist to confirm.  Not sure what cause these episodes of wheels, muscle and joint aches and fatigue.  Patient claims that immediately after the anthrax shots in 98, there were these.  Symptoms now they are persisting.  At same time however also had a lot of terrible personal problems and unfaithful wife who gave him some diseases taht the patient didn't treat adequately.  Follow up:  Patient did not recover from adverse event.  Patient's current duty status is light duty.  Patient still being evaluated for possible administrative separation.  Approximately 60 days due to time lost getting treatment and doctor visits. Patient has been evaluated by a physician or health care provider, but all assure me that side effects are temporary; thus my conditions is not related.  Names are attached on copies of records; however I believe those side effects are not going away.  Patient did not receive any further shots since reported events.
The day after the vaccine when I got home, I noticed two little itchy spots on my breast. Then within an hour my whole torso was covered in hives. I tried taking Benadryl at home but the hives were still spreading and getting worse. I went to Urgent care on 09/07/2021 and they prescribed some Prednisone. I was told to take Benadryl. It was getting worse and was very itchy and I visited the ER on 09/09/2021 because I was covered in hives from the neck down. I was given Epinephrine and I am finished with the Prednisone. It has been almost two weeks and the hives are still present especially on my hands today. They are consistently on my torso and legs, but they are coming and going on my arms. The ones on my arms are new and I have two on my eye. They are big spots that become large and raised patches. They get worse in the evening and become raised and itchy.
This spontaneous case, initially received from a pharmacist on 29-Jan-2018, concerning a 41-year-old adult female patient. This report was linked to case 201800198. The patient's medical history and concomitant medications were not reported. It was reported that, AFLURIA QUADRIVALENT vaccine (single, opened MDV (multi dose vial)) underwent temperature excursion (first excursion) at room temperature of 76-degree F for 30-40 minutes (not more than an hour). On 25-Jan-2018, the patient was administered with AFLURIA QUADRIVALENT (dose: 0.5 ml, route of administration: intramuscular, anatomical location: left deltoid, batch number; 00944611A and expiry date: 30-Jun-2018) which underwent temperature excursion. It was stated that, the patient did not experience any adverse events after the vaccination. The reporter assessed the events as non-serious. Non-significant follow up received on 06-Feb-2018: The reporter confirmed that, the patient did not experience any adverse events after the vaccination. The narrative was amended accordingly.
Mother states child had red blotchy rash around site of DTAP the morning after injection. By that afternoon, rash had spread to back of neck, left chest and both feet. Feet appear swollen. No treatment at time of phone call but MD notified. On 6/14/01, swelling down and rash subsiding.
Information has been received from a physician concerning a patient who on 06-OCT-2009 was vaccinated with a second dose of ROTATEQ intramuscularly rather than oral administration.  The patient was kept in the office for an additional ten minutes with no reported problems.  The patient was not experiencing any known symptoms.  Follow-up information was received from a health care professional, concerning a female patient with no illnesses at the time of vaccination and no medical history, (birth weight reported 24.26 grams), who was vaccinated with a second dose of ROTATEQ (lot # 663839/0316Y), batch # 0316Y) into the left leg.  On the same day, the patient experienced fever and loss of appetite.  No laboratory diagnostics tests were performed.  On 08-OCT-2009, the patient had recovered.  No further information is available.
Vaccine injected from a vial (storage more than 30 days); Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine injected from a vial (storage more than 30 days)) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine injected from a vial (storage more than 30 days)). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Vaccine injected from a vial (storage more than 30 days)) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was reported. No treatment information was reported.
Reports feeling of chills, debilitating headache, muscle aches.  No fever.  Tylenol does not help.  Unable to get out of bed.
Sore arm reported by pt. has received a TORADOL shot approximately 2 week later.
Information has been received from a Licensed Visiting Nurse concerning a 41 year old female patient who was vaccinated with her first full Hep B series (route, dose and manufacturer unknown) on 11-OCT-2005, 26-JAN-2006 and 19-APR-2006. The patient had a negative hepatitis B antibody titer after completing her first Hep B series. The patient was vaccinated her second full Hep B (1.0mL) series intramuscularly on 08-JUN-2010, 09-JUL-2010 and 10-JAN-2011. Additional information has been requested.
Swelling, redness, tenderness left thigh. Treated for abscess left thigh. PO then IV then PO antibiotics.
Patient had no symptoms, patient was told to contact doctor if any symptoms occurred such as redness, pain, swelling, joint pain, body aches, drowsiness, diarrhea. Patient did not report any symptoms.
Later that evening I developed horrible anxiety and  rapid HR which has caused me to have to stop taking my current meds because of this.  I have been severely tired and has had chills off and on for about a week.  Mild headaches has also been associated as well
Information has been received from a registered nurse concerning an adult female patient who was vaccinated with two doses of either MMRII or rubella virus vaccine live (second generation) and failed to seroconvert. No adverse reactions were noted. FOLLOW-UP information received indicated that the "young woman" thought she vaccinated with one dose of MMRII, as a child. Approximately two year ago, in approximately 1999, she was vaccinated with one dose of rubella virus vaccine live (second generation) A rubella titer obtained should receive a third "rubella vaccine". She stated that she did not have any further vaccination information, including lot members, as the vaccines were not administered there. In addition, she stated that the patient's  sister had "the same problem" with her rubella vaccinations (WAES01081730). No further is available.
Sore arm for 36 hours then 8 days later swelling, heat and itching in an oval around injection site - diameter about 3 inches. Just monitoring - no treatment.
tested covid positive on nov 11 without symptoms(my husband also positive) and have gotten 2 negative tests since, got the vaccine jan 6. then jan 16 tested covid positive with intense body aches, mild respiratory symptoms and no taste or smell
prolonged high pitched irritable crying for 3-4 hrs /p admin. of DTP #1, by report from mother exact time interval /p immunization unknown-occurred within 8 hrs
CONSTANT PAIN AND NUMBNESS IN FINGERTIPS, FINGER JOINTS AND TOES
Today is 8 days after covid vaccination. Skin is raised and red about 4 inches around injection site in right arm. Injection site is sore to the touch.
This spontaneous report as received from a healthcare worker refers to unknown number of patients of unknown age and gender. Current conditions and medical history were not reported. On an unknown date, the patients were vaccinated with 6 doses of improperly stored MMR II (unknown dose, strength and dose). Concomitant medications were not reported. No adverse effects were reported. The outcome of the events was unknown. No product quality complaint was involved. This is one of several reports received from the same reporter. Additional information has been requested.
Less thank 15 minutes son started to get dizzy and had ringing in his right ear. He was given an ivepack for his next and told to take deep breathes and stay seated. Then hr later he started complaining of ear ache on the  right side. He does not have history of ear aches but gave him tylenol and applied hot wet washcloth on his ear. No fever. Or chills at the time.
Noticed my eyes were completely dilated and felt dizzy. After about an hour of noticing eyes, I started to feel really funny in my chest with pressure, dizziness blurry vision, racing heart.  I checked blood pressure and it was 220/110. I tried to lay back and it felt worse. At the same time I was nauseated and felt like I was going to have diarrhea and vomit at the same time.  Started with severe vomiting and chills that felt more like tremors than chills. The vomiting stoped during the night but my blood pressure stayed elevated for three days starting around 180/110 to 180/100. Finally it slowly came down to around 150/90 for two more days.  Then back to normal at 130/80.
Myalgia, Arthralgia, NauseaVomiting, site discomfort- other symptoms both doses Narrative:  Other Relevant History:
Patient receive a booster dose when he should have gotten a third dose; This spontaneous case was reported by a pharmacist and describes the occurrence of INCORRECT DOSE ADMINISTERED (Patient receive a booster dose when he should have gotten a third dose) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced INCORRECT DOSE ADMINISTERED (Patient receive a booster dose when he should have gotten a third dose). At the time of the report, INCORRECT DOSE ADMINISTERED (Patient receive a booster dose when he should have gotten a third dose) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported.  No treatment information was provided.
-swollen and painful left shoulder            - fatigue and weakness -swollen under left armpit                              -swollen node above left clavicle -temp 100.0 fever -body aches
530PM rt eye drooped, had sz, foaming @ mouth; seen in ER; was not responding; determined that it was a rxn to DTP-did not have another seizure; never had a full arrest;
doses were stored in an appropriately functioning freezer and thawed prior to administration (Vaccine was expired on 27Oct2021); administered dose after the expiration date.; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (administered dose after the expiration date.) and PRODUCT STORAGE ERROR (doses were stored in an appropriately functioning freezer and thawed prior to administration (Vaccine was expired on 27Oct2021)) in a  patient of an unknown age and gender who received mRNA-1273 (Spikevax) (batch no. 038C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 23-Feb-2022, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 23-Feb-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (administered dose after the expiration date.). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (doses were stored in an appropriately functioning freezer and thawed prior to administration (Vaccine was expired on 27Oct2021)). At the time of the report, EXPIRED PRODUCT ADMINISTERED (administered dose after the expiration date.) and PRODUCT STORAGE ERROR (doses were stored in an appropriately functioning freezer and thawed prior to administration (Vaccine was expired on 27Oct2021)) outcome was unknown.        For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported.  No treatment medications were reported.
delayed hypersensitivity: redness, firmness, increased heat and muscle weakness at and around injection site. Started about 1 week after injection and has lasted about 4-5 days, worst symptoms were 9 days past injection day. Took antihistamine for some relief
I noticed my arm was itching I went to the bathroom and the injection site was red and warm to the touch. There's a little bit of a lump.
Dizziness; Nausea; red rash that covers her neck, abdomen and underarm; rash that appears like a sunburn and blotchy; Severe arm soreness; No appetite; Chills; Headache; Muscle ache; Severe fatigue; temp of 100F; A report was received from a healthcare facility staff member concerning a 51-year old, female patient who was participating in the mRNA-1273 Program and experienced severe fatigue, muscle ache, headache, chills, severe arm soreness, no appetite, red rash that covers her neck, abdomen and underarm that appears like a sunburn and blotchy, severe headache that starts from the base of the neck to the top of her head, nausea, and dizziness.  The patient's medical history, as provided by the reporter, included migraines and breast cancer. Concomitant medications reported included ascorbic acid, betacarotene, biotin, calcium carbonate, calcium pantothenate, calcium phosphate dihydrate, chromic chloride, colecalciferol, copper sulfate, cyanocobalamin, dl-alpha tocopheryl acetate, ferrous fumarate, folic acid, lycopene, magnesium oxide heavy, manganese sulfate monohydrate, nicotinamide, phytomenadione, potassium iodide, pyridoxine hydrochloride, retinol acetate, riboflavin, sodium selenate, thiamine mononitrate, xantofyl, zinc oxide, colecalciferol, and tamoxifen.  On 29 Dec 2020, approximately 0-3 days prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 intramuscularly in the right arm for prophylaxis of COVID-19 infection.  On 29 Dec 2020, in the afternoon, the patient started to feel severe fatigue, muscle ache, heache, chills, and experienced sever arm soreness, temp of 100 F and no appetite through the night. On 31 Dec 2020, her headache became severe, and she experienced chills, a blotchy, and a red rash that covers her neck, abdomen and underarm that appears like a sunburn. On 01 Jan 2021, the rash was still evident, she had no appetite, a sever headache that started at the base of her neck to the top of her head, nausea, and dizziness. On 03 Jan 2020, the patient reported all symptoms were still the same. The patient reported that despite taking pain killers and migraine medication, the pain persisted. Treatment for the event included ibuprofen on 29 Dec 2020, paracetamol every 6-7 hours, and Imitrex on 30 Dec 2020 and 01 Jan 2021.   Action taken with mRNA-1273 in response to the events was not reported.  The outcome of the events were unknown.; Reporter's Comments: This case concerns a female of unknown age with NS events of unexpected dizziness, decreased appetite, rash erythematous, rash macular, pain in extremity and expected fatigue, fever, chills, headache, myalgia, nausea.  Event onset on Day 2 after the first dose of mRNA-1273. Treated with ibuprofen, paracetamol, Imitrex. Based on current available information and temporal association between use of the product and the start date of the event, a causal relationship cannot be excluded.
Severe pain in neck and right shoulder approx. 3 hours after injection. pain slowly subside after 3 days Still a little sore, but mostly pain free No injury occurred